Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Parodi

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Oncotarget|January 30, 2016
Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrenceAlessia Parodi, Paolo Traverso, Francesca Kalli, et al.
Frontiers in Immunology|September 8, 2023
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancersChiara M Biatta, Michele Paudice, Marco Greppi, et al.
Oncotarget|August 27, 2016
AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanomaGiuseppina Conteduca, Daniela Fenoglio, Alessia Parodi, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of AktRoberto Würth, Alessandra Pattarozzi, Monica Gatti, et al.
AIDS (London, England)|August 30, 2024
Distinct features of immune activation and exhaustion markers in people with perinatally acquired HIVLucia Taramasso, Chiara Dentone, Isabella Cama, et al.
Journal of Medical Virology|April 29, 2021
Characterization of T lymphocytes in severe COVID-19 patientsDaniela Fenoglio, Chiara Dentone, Alessia Parodi, et al.
Scientific Reports|July 26, 2017
A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant responseEmiliano Manzo, Adele Cutignano, Dario Pagano, et al.
Ejhaem|April 18, 2024
Early CAR<sup>-</sup> CD4<sup>+</sup> T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphomaMassimiliano Gambella, Simona Carlomagno, Rosa Mangerini, et al.
Brain, Behavior, and Immunity|May 4, 2018
White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: Combined DTI and immunological investigation in the different phases of bipolar disorderPaola Magioncalda, Matteo Martino, Samuele Tardito, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancerDaniela Fenoglio, Paolo Traverso, Alessia Parodi, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Oncotarget|January 30, 2016
Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrenceAlessia Parodi, Paolo Traverso, Francesca Kalli, et al.
Frontiers in Immunology|September 8, 2023
The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancersChiara M Biatta, Michele Paudice, Marco Greppi, et al.
Oncotarget|August 27, 2016
AIRE polymorphism, melanoma antigen-specific T cell immunity, and susceptibility to melanomaGiuseppina Conteduca, Daniela Fenoglio, Alessia Parodi, et al.
Cell Cycle (Georgetown, Tex.)|December 21, 2012
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of AktRoberto Würth, Alessandra Pattarozzi, Monica Gatti, et al.
AIDS (London, England)|August 30, 2024
Distinct features of immune activation and exhaustion markers in people with perinatally acquired HIVLucia Taramasso, Chiara Dentone, Isabella Cama, et al.
Journal of Medical Virology|April 29, 2021
Characterization of T lymphocytes in severe COVID-19 patientsDaniela Fenoglio, Chiara Dentone, Alessia Parodi, et al.
Scientific Reports|July 26, 2017
A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant responseEmiliano Manzo, Adele Cutignano, Dario Pagano, et al.
Ejhaem|April 18, 2024
Early CAR<sup>-</sup> CD4<sup>+</sup> T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphomaMassimiliano Gambella, Simona Carlomagno, Rosa Mangerini, et al.
Brain, Behavior, and Immunity|May 4, 2018
White matter microstructure alterations correlate with terminally differentiated CD8+ effector T cell depletion in the peripheral blood in mania: Combined DTI and immunological investigation in the different phases of bipolar disorderPaola Magioncalda, Matteo Martino, Samuele Tardito, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancerDaniela Fenoglio, Paolo Traverso, Alessia Parodi, et al.
Pageof 6